Literature DB >> 28521513

Astragalus Polysaccharides Attenuate Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats.

Lin-Bo Yuan1,2,3,4, Chun-Yan Hua3,4, Sheng Gao5, Ya-Ling Yin6, Mao Dai1,2, Han-Yan Meng4,7, Piao-Piao Li4,8, Zhong-Xin Yang4,8, Qing-Hua Hu1,2.   

Abstract

Astragalus polysaccharides (APS) have been shown to possess a variety of biological activities including anti-oxidant and anti-inflammation functions in a number of diseases. However, their function in pulmonary arterial hypertension (PAH) is still unknown. Rats received APS (200[Formula: see text]mg/kg once two days) for 2 weeks after being injected with monocrotaline (MCT; 60[Formula: see text]mg/kg). The pulmonary hemodynamic index, right ventricular hypertrophy, and lung morphological features of the rat models were examined, as well as the NO/eNOS ratio of wet lung and dry lung weight and MPO. A qRT-PCR and p-I[Formula: see text]B was used to assess IL-1[Formula: see text], IL-6 and TNF-[Formula: see text] and WB was used to detect the total I[Formula: see text]B. Based on these measurements, it was found that APS reversed the MCT-induced increase in mean pulmonary arterial pressure (mPAP) (from 32.731[Formula: see text]mmHg to 26.707[Formula: see text]mmHg), decreased pulmonary vascular resistance (PVR) (from 289.021[Formula: see text]mmHg[Formula: see text][Formula: see text] min/L to 246.351[Formula: see text]mmHg[Formula: see text][Formula: see text][Formula: see text]min/L), and reduced right ventricular hypertrophy (from 289.021[Formula: see text]mmHg[Formula: see text][Formula: see text][Formula: see text]min/L to 246.351 mmHg[Formula: see text][Formula: see text][Formula: see text]min/L) ([Formula: see text]0.05). In terms of pulmonary artery remodeling, the WT% and WA% decreased with the addition of APS. In addition, it was found that APS promoted the synthesis of eNOS and the secretion of NO, promoting vasodilation and APS decreased the MCT-induced elevation of MPO, IL-1[Formula: see text], IL-6 and TNF-[Formula: see text], reducing inflammation. Furthermore, APS was able to inhibit the activation of pho-I[Formula: see text]B[Formula: see text]. In couclusion, APS ameliorates MCT-induced pulmonary artery hypertension by inhibiting pulmonary arterial remodeling partially via eNOS/NO and NF-[Formula: see text]B signaling pathways.

Entities:  

Keywords:  Astragalus Polysaccharides; NF-B; Nitric Oxide; Pulmonary Arterial Hypertension

Mesh:

Substances:

Year:  2017        PMID: 28521513     DOI: 10.1142/S0192415X17500410

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  6 in total

Review 1.  Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.

Authors:  Zhijie Yu; Jun Xiao; Xiao Chen; Yi Ruan; Yang Chen; Xiaoyuan Zheng; Qiang Wang
Journal:  Chin Med       Date:  2022-01-15       Impact factor: 5.455

Review 2.  Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.

Authors:  Zhifeng Xue; Yixuan Li; Mengen Zhou; Zhidong Liu; Guanwei Fan; Xiaoying Wang; Yan Zhu; Jian Yang
Journal:  Front Pharmacol       Date:  2021-11-09       Impact factor: 5.810

3.  Astragalus polysaccharide inhibits radiation-induced bystander effects by regulating apoptosis in Bone Mesenchymal Stem Cells (BMSCs).

Authors:  Yi-Ming Zhang; Li-Ying Zhang; Heng Zhou; Yang-Yang Li; Kong-Xi Wei; Cheng-Hao Li; Ting Zhou; Ju-Fang Wang; Wen-Jun Wei; Jun-Rui Hua; Yun He; Tao Hong; Yong-Qi Liu
Journal:  Cell Cycle       Date:  2020-10-30       Impact factor: 4.534

Review 4.  Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Ina Yosifova Aneva; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

Review 5.  A Review of the Pharmacological Action of Astragalus Polysaccharide.

Authors:  Yijun Zheng; Weiyu Ren; Lina Zhang; Yuemei Zhang; Dongling Liu; Yongqi Liu
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

6.  Ginseng berry polysaccharides on inflammation-associated colon cancer: inhibiting T-cell differentiation, promoting apoptosis, and enhancing the effects of 5-fluorouracil.

Authors:  Chong-Zhi Wang; Lifei Hou; Jin-Yi Wan; Haiqiang Yao; Jinbin Yuan; Jinxiang Zeng; Chan Woong Park; Su Hwan Kim; Dae Bang Seo; Kwang-Soon Shin; Chun-Feng Zhang; Lina Chen; Qi-Hui Zhang; Zhi Liu; Clara Sava-Segal; Chun-Su Yuan
Journal:  J Ginseng Res       Date:  2019-01-02       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.